SG159894G - A pharmaceutical composition adapted for transdermal delivery of an opoid drug - Google Patents

A pharmaceutical composition adapted for transdermal delivery of an opoid drug

Info

Publication number
SG159894G
SG159894G SG159894A SG159894A SG159894G SG 159894 G SG159894 G SG 159894G SG 159894 A SG159894 A SG 159894A SG 159894 A SG159894 A SG 159894A SG 159894 G SG159894 G SG 159894G
Authority
SG
Singapore
Prior art keywords
opoid
drug
pharmaceutical composition
transdermal delivery
composition adapted
Prior art date
Application number
SG159894A
Other languages
English (en)
Inventor
Majid Mahjour
Bernadette E Mauser
Mahdi B Fawzi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP88905280A priority Critical patent/EP0375689B1/fr
Priority to PCT/US1988/001666 priority patent/WO1988009676A1/fr
Priority to JP63504925A priority patent/JPH02503672A/ja
Priority to US07/364,549 priority patent/US4879297A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to SG159894A priority patent/SG159894G/en
Priority to HK149794A priority patent/HK149794A/xx
Publication of SG159894G publication Critical patent/SG159894G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG159894A 1987-06-01 1994-11-01 A pharmaceutical composition adapted for transdermal delivery of an opoid drug SG159894G (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP88905280A EP0375689B1 (fr) 1987-06-01 1988-05-16 Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid.
PCT/US1988/001666 WO1988009676A1 (fr) 1987-06-01 1988-05-16 Acides gras et leurs esters a petite chaine utilises a titre de renforcateurs de penetration dans des systemes aqueux
JP63504925A JPH02503672A (ja) 1987-06-01 1988-05-16 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
US07/364,549 US4879297A (en) 1987-06-01 1989-05-23 Fatty acids and their small chain esters as penetration enhancers in aqueous systems
SG159894A SG159894G (en) 1987-06-01 1994-11-01 A pharmaceutical composition adapted for transdermal delivery of an opoid drug
HK149794A HK149794A (en) 1987-06-01 1994-12-30 A pharmaceutical composition adapted for transdermal delivery of an opoid drug

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5652087A 1987-06-01 1987-06-01
SG159894A SG159894G (en) 1987-06-01 1994-11-01 A pharmaceutical composition adapted for transdermal delivery of an opoid drug

Publications (1)

Publication Number Publication Date
SG159894G true SG159894G (en) 1995-03-17

Family

ID=26664471

Family Applications (1)

Application Number Title Priority Date Filing Date
SG159894A SG159894G (en) 1987-06-01 1994-11-01 A pharmaceutical composition adapted for transdermal delivery of an opoid drug

Country Status (5)

Country Link
EP (1) EP0375689B1 (fr)
JP (1) JPH02503672A (fr)
HK (1) HK149794A (fr)
SG (1) SG159894G (fr)
WO (1) WO1988009676A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
CA2002299A1 (fr) * 1988-11-10 1990-05-10 Eugene G. Drust Composes pour l'administration transdermique de sels de buprenorphine
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5736553A (en) * 1988-12-15 1998-04-07 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
WO1991002553A2 (fr) * 1989-08-17 1991-03-07 Schering Corporation Pastille dotee de stimulateurs de penetration pour la liberation transdermique de nitroglycerine
DE3939376C1 (fr) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
EP0432945A1 (fr) * 1989-12-12 1991-06-19 Warner-Lambert Company Système d'administration transdermique pour le traitement de la cocainomanie et de l'héroinomanie
NZ237489A (en) * 1990-04-18 1995-07-26 Alza Corp Device for electrotransport and reservoir therefor containing a fatty acid as permeation enhancing agent
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
EP0748629A4 (fr) * 1994-03-11 1997-08-20 Sekisui Chemical Co Ltd Emplatre a absorption percutanee comprenant un sel d'addition d'acide de la morphine
CA2181364A1 (fr) * 1994-11-17 1996-05-30 Kaneto Uekama Preparation absorbable par voie percutanee
WO1997040702A1 (fr) * 1996-04-29 1997-11-06 K.U. Leuven Research & Development Composition pour administration orale presentant une haute efficacite d'absorption et procede de preparation de ladite composition
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
JP4659943B2 (ja) 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
WO2006085521A1 (fr) * 2005-02-10 2006-08-17 Nihon University Composition medicinale destinee a une absorption transdermique, contenant un antagoniste des recepteurs opioides, un procede de production de celui-ci et un procede destine a favoriser l’absorption transdermique de l’antagoniste
JP4807974B2 (ja) * 2005-06-30 2011-11-02 帝國製薬株式会社 経皮吸収促進組成物
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
CA2659733A1 (fr) 2006-07-31 2008-02-07 3M Innovative Properties Company Compositions topiques sterilisees de 1 (2 methylpropyl) 1h imidazo[4,5 c]quinolin 4 amine
WO2008106571A2 (fr) 2007-02-28 2008-09-04 Abbott Laboratories Formulations parentérales de buprénorphine à libération prolongée
EP2259780A2 (fr) 2008-02-28 2010-12-15 Syntropharma Limited Composition pharmaceutique comprenant de la naltrexone
DE102011076653A1 (de) 2011-05-27 2012-11-29 Acino Ag Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure
JP6370802B2 (ja) 2012-12-28 2018-08-08 テイコク ファーマ ユーエスエー インコーポレーテッド 持続性ブプレノルフィン経皮送達組成物およびそれの使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids

Also Published As

Publication number Publication date
JPH02503672A (ja) 1990-11-01
EP0375689A1 (fr) 1990-07-04
HK149794A (en) 1995-01-06
WO1988009676A1 (fr) 1988-12-15
EP0375689B1 (fr) 1992-08-12

Similar Documents

Publication Publication Date Title
SG159894G (en) A pharmaceutical composition adapted for transdermal delivery of an opoid drug
US5232438B1 (en) Transdermal electrotransport delivery of analgesic drugs
ZA892321B (en) Pharmaceutical composition for systemic transdermal administration
IL72684A (en) Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
NZ216029A (en) Device for transdermal delivery of nitroglycerine and pharmaceutical composition
GB8609219D0 (en) Transdermal delivery of drugs
EP0177329A3 (en) Device for transdermal drug administration
IL76061A0 (en) Pharmaceutical compositions for transdermal delivery of opioids
IL86076A0 (en) Transdermal drug delivery device
AU2341388A (en) Syringe for a liquid pharmaceutical composition
GB2173704B (en) Drug delivery device for programmed delivery of beneficial drug
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
EP0237263A3 (en) Transdermal drug delivery system
GB8615106D0 (en) Transdermal drug delivery device
EP0296553A3 (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
GB2192134B (en) Transdermal delivery of drugs
IE860785L (en) Composition for delivery of orally administered drugs
EP0285550A3 (en) A percutaneous-administration-type pharmaceutical preparation of nitroglycerin
ZA91409B (en) Transdermal administration of zwitterionic drugs
AU2617288A (en) Pharmaceutical formulations for transdermal administration
IL87921A0 (en) Pharmaceutical composition for piperidinoalkanol derivatives
AU4968585A (en) Physiological means of enhancing transdermal delivery of drugs
GB8814766D0 (en) Electrode assembly for transdermal drug delivery
AU1491588A (en) Bandage for transdermal delivery of drugs
IL93143A0 (en) Transdermal drug delivery composition